83 Preclinical Evaluation of LNK001: Stringent AND-Gate Fidelity and Potent Efficacy of a Dual-Antigen CAIX/ENPP3 CAR T Cell Therapy for Clear Cell Renal Cell Carcinoma
Mark Wallet, Rebecca Larson, Yogin Patel, Janette Sutton, Bryan Smith, Colin Farrell, Angeles Estelles, Zeynep Wheeler, Kazuteru Hasegawa, Benjamin Bauer, Jakob McBroome, Diego Vargas-Inchaustegui, Alexander Bankovich, Regina Lin · 2026
Read 83 Preclinical Evaluation of LNK001: Stringent AND-Gate Fidelity and Potent Efficacy of a Dual-Antigen CAIX/ENPP3 CAR T Cell Therapy for Clear Cell Renal Cell Carcinoma by Mark Wallet, Rebecca Larson, Yogin Patel, Janette Sutton, Bryan Smith, Colin Farrell, Angeles Estelles, Zeynep Wheeler, Kazuteru Hasegawa, Benjamin Bauer, Jakob McBroome, Diego Vargas-Inchaustegui, Alexander Bankovich, Regina Lin (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13535431.txt.
Description
Mark Wallet and co-authors report early lab tests in 2026 of a cell therapy for kidney cancer. The therapy trains a patient's own immune cells to hunt cancer, a method that works well in blood cancers but has struggled in solid tumors. A key risk is harm to healthy tissue that shares the target.
Their cells fire only when they spot two targets at once on a cell, CAIX and ENPP3, like an AND gate in a circuit. Healthy tissue rarely shows both, so it should be spared. In lab tests the cells killed tumor cells with force and held their strict rule. Human trials would be the next step.
Catalog record
| CREATOR | Mark Wallet, Rebecca Larson, Yogin Patel, Janette Sutton, Bryan Smith, Colin Farrell, Angeles Estelles, Zeynep Wheeler, Kazuteru Hasegawa, Benjamin Bauer, Jakob McBroome, Diego Vargas-Inchaustegui, Alexander Bankovich, Regina Lin |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 5 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |